非法摇头丸片剂分析：对急诊科临床管理的启示
Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.
作者信息
Sherlock K, Wolff K, Hay A W, Conner M
机构信息
Ethnicity and Health Unit, Faculty of Health, University of Central Lancashire, Preston.
出版信息
J Accid Emerg Med. 1999 May;16(3):194-7. doi: 10.1136/emj.16.3.194.
OBJECTIVE
To examine the composition of illicitly manufactured "ecstasy" tablets sold on the UK drugs market.
METHODS
Analysis by gas chromatography of 25 illicit ecstasy tablets handed in under amnesty to Leeds Addiction Unit.
RESULTS
Illicitly manufactured ecstasy tablets contain a range of ingredients, of widely differing concentrations, and even tablets with the same brand name have variable concentrations of active ingredients. Concentrations of 3,4-methylenedioxymethamphetamine (MDMA) more popularly known as ecstasy, varied 70-fold between tablets. Nine tablets contained neither MDMA nor related analogues.
CONCLUSIONS
These results have implications for emergency workers attending to those who have become casualties of the drug ecstasy. Those claiming to have ingested ecstasy may actually have taken other agents that require different clinical management.
目的
检测在英国毒品市场上销售的非法制造的“摇头丸”片剂的成分。
方法
对根据大赦令上交至利兹成瘾科的25片非法摇头丸进行气相色谱分析。
结果
非法制造的摇头丸片剂含有一系列成分，浓度差异很大，甚至同一品牌的片剂其活性成分浓度也各不相同。俗称摇头丸的3,4-亚甲基二氧甲基苯丙胺（MDMA）的浓度在不同片剂之间相差70倍。9片药片中既不含MDMA也不含相关类似物。
结论
这些结果对救治摇头丸中毒人员的急救人员具有启示意义。那些声称摄入摇头丸的人实际上可能服用了其他需要不同临床处理的药物。
Zotero 插件